hypertension kidney stones hypercholestrolemia. the prevalence of "true" treatment-...

101
Hypertension Kidney Stones Hypercholestrolemia

Upload: ferdinand-peters

Post on 01-Jan-2016

226 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Hypertension Kidney Stones Hypercholestrolemia

Page 2: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

The prevalence of "true" treatment-resistant hypertension (HTN) is:

 A) Unknown B) Approximately 20% in patients

with HTN C) 10% to 15% in patients without diabetes mellitus (DM) or chronic

kidney disease (CKD) D) Up to 33% in patients with DM

and/or CKD

Page 3: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  A) Unknown

Page 4: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is a cause of pseudoresistance to HTN

treatment? A) Poor adherence with prescribed medications

 B) Inaccurate measurement of blood pressure (BP)

 C) "White-coat" HTN D) All the above

Page 5: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) All the above

Page 6: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

All the following are associated with resistant HTN, except:

 A) Older age B) Obesity

 C) White ethnicity D) Residence in southeastern

United States

Page 7: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

ANswer

• C) White ethnicity

Page 8: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following has not been shown to interfere

with control of BP? A) Amphetamines B) Coenzyme Q10

 C) Alcohol D) Oral contraceptives

Page 9: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  B) Coenzyme Q10

Page 10: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Studies suggest that cyclooxygenase (COX)-2 selective inhibitors induce

_______ hypertensive responses than COX-2 nonselective

inhibitors. A) Fewer B) Milder

 C) Stronger D) A and B

Page 11: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) A and B

Page 12: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Measurements of urinary metanephrine and normetanephrine

are the recommended screening tests for which of the following causes of

secondary HTN? A) Cushing disease

 B) Glucocorticoid remediable aldosteronism

 C) Renal artery stenosis D) Pheochromocytoma

Page 13: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) Pheochromocytoma

Page 14: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is not recommended as a pharmacologic treatment of resistant

HTN? A) Combining agents with different

mechanisms of action B) Using a long-acting thiazide

 C) Adding an aldosterone receptor antagonist as a "last resort"

 D) Using a loop diuretic in patients with stage 4 CKD

Page 15: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) Adding an aldosterone receptor antagonist as a "last resort“

• Add it earlier

Page 16: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

A weight loss of ≈10 kg plus regular exercise can reduce a

patient's BP by: A) 5 to 10 mm Hg B) 5 to 20 mm Hg C) 8 to 15 mm Hg

 D) 20 to 30 mm Hg

Page 17: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) 20 to 30 mm Hg

Page 18: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Sedentary patients who initiate exercise therapy for HTN should

begin with: A) 10-min walks twice per week B) 15 min of moderate intensity

activity 5 to 7 days/wk C) 30 min of brisk walking 5

days/wk D) 30 to 45 min of moderate

activity 3 days/wk

Page 19: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  A) 10-min walks twice per week

Page 20: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Choose the correct statements about the effects of exercise on reduction of BP.Resistance exercise is

more effective than aerobic exerciseAerobic exercise is more effective than resistance

exerciseSeveral short bouts of exercise are more effective

than one longer boutOne longer bout of exercise is more effective than

several short bouts

 A) 1,3 B) 2,3 C) 1,4 D) 2,4

Page 21: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• Aerobic exercise is more effective than resistance exercise

• Several short bouts of exercise are more effective than one longer bout

•  B) 2,3

Page 22: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

 Which of the following can be associated with comorbid

insomnia? A) Depression

 B) Gastroesophageal reflux disease

 C) Menopausal symptoms D) All the above

Page 23: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) All the above

Page 24: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Periodic limb movement disorder A) Diagnosed by polysomnography; treated

with dopaminergic agents B) Diagnosed by clinical history and physical

examination; begins or worsens with rest C) Occurs during REM sleep; muscle atonia;

more common in older women D) Tends to occur in neurodegenerative

disorders and in older men; no muscle atonia

Page 25: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• A) Diagnosed by polysomnography; treated with dopaminergic agents

Page 26: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Restless legs syndrome A) Diagnosed by polysomnography; treated with

dopaminergic agents B) Diagnosed by clinical history and physical

examination; begins or worsens with rest  C) Occurs during REM sleep; muscle atonia; more

common in older women D) Tends to occur in neurodegenerative disorders

and in older men; no muscle atonia

Page 27: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Diagnosed by clinical history and physical examination; begins or worsens with rest 

Page 28: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Rapid eye movement (REM) sleep behavior disorder

 A) Diagnosed by polysomnography; treated with dopaminergic agents

 B) Diagnosed by clinical history and physical examination; begins or worsens with rest

 C) Occurs during REM sleep; muscle atonia; more common in older women

 D) Tends to occur in neurodegenerative disorders and in older men; no muscle atonia

Page 29: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• D) Tends to occur in neurodegenerative disorders and in older men; no muscle atonia

Page 30: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Choose the correct statement about cognitive behavioral therapy for

insomnia. A) Rarely as effective as medications

 B) Often preferred over medications by patients

 C) Duration of effects much shorter than that of medications

 D) Not recommended for patients with depression

Page 31: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Often preferred over medications by patients

Page 32: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

 Which of the following is least associated with heparin-

induced thrombocytopenia? A) Unfractionated heparin B) Low molecular weight

heparin C) Fondaparinux

 D) Combination of any of above

Page 33: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  C) Fondaparinux

Page 34: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following types of kidney stones is more common in

women than in men? A) Calcium oxalate

 B) Struvite C) Uric acid D) Cystine

Page 35: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  B) Struvite

Page 36: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is most sensitive for identifying kidney

stones? A) Plain film radiography

 B) Computed tomography (CT) C) Intravenous (IV) pyelography

 D) Ultrasonography

Page 37: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  B) Computed tomography (CT)

Page 38: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Uric acid stones are visible on plain film radiography but not on

CT. A) True B) False

Page 39: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  B) False

Page 40: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following was shown to be least effective in the treatment of pain associated with

kidney stones? A) IV fentanyl B) IV ketorolac

 C) Intramuscular ketorolac D) Hydromorphone

Page 41: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  C) Intramuscular ketorolac

Page 42: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is recommended for facilitating passage of proximal stones?

 A) Tamulosin B) Nifedipine C) Deflazacort D) Diclofenac

Page 43: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• A) Tamulosin

Page 44: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

 All the following beverages are associated with reduced stone

formation, except: A) Coffee

 B) Tea C) Alcohol

 D) Grapefruit juice

Page 45: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• D) Grapefruit juice

Page 46: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following was recommended as the treatment of choice for the management of hypertension in patients with end-stage renal disease

(ESRD)? A) Direct renin inhibitors

 B) Angiotensin-converting enzyme inhibitors and angiotensin receptor

blockers C) β-blockers

 D) Calcium channel blockers

Page 47: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Page 48: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

High hemoglobin levels in patients with ESRD are related to

higher incidence of stroke, myocardial infarction, access

thrombosis, and erythropoietin-secreting tumor.

 A) True B) False

Page 49: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  A) True

Page 50: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Choose the correct statement about phosphate binders in hyperparathyroidism.

 A) Calcium acetate associated with severe reflux disease

 B) Sevelamer most effective and has lowest pill burden

 C) Calcimimetics highly effective and approved for parathyroid hormone suppression

 D) Lanthanum carbonate associated with excess cardiovascular death and hyperlipidemia

Page 51: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) Calcimimetics highly effective and approved for parathyroid hormone suppression

Page 52: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Primary care of patients with ESRD should involve:

 A) Effective communication between nephrologist and primary care physician B) Understanding of drug dosing, cancer

screening, and pain management C) Coordination of end-of-life care

 D) All the above 

Page 53: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) All the above 

Page 54: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is the most common source of infection

in the elderly? A) Skin and soft tissue B) Gastrointestinal tract C) Genitourinary tract

 D) Lower respiratory tract

Page 55: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) Genitourinary tract

Page 56: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following contribute to immunocompromise in the elderly?Decreased T cell

and B cell activityDecreased antibody titers

Poor circulationLoss of natural barriers

Diminished cough reflexProblems in living and home environment

 A) 1,3,5 B) 2,4,6

 C) 1,2,3,4,5 D) 1,2,3,4,5,6

Page 57: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) 1,2,3,4,5,6

Page 58: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

The following statements about fever in the elderly are true,except:

 A) The elderly have diminished thermoregulatory capacity

 B) Less likely than young individuals to develop hypothermia in response to serious

infections C) Absence of fever should not rule out

consideration of serious infection D) Fever in the elderly should be redefined to

start at lower oral and rectal temperatures

Page 59: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Less likely than young individuals to develop hypothermia in response to serious infections

Page 60: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Infection should be considered in the elderly in the presence of

delirium and tachypnea. A) True B) False

Page 61: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• A) True

Page 62: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is a risk factor in the development of venous thromboembolism? A) Long-distance air travel

 B) Compound heterozygosity for factor V Leiden and prothrombin

mutation C) Elevated factor VIII

 D) All the above

Page 63: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) All the above

Page 64: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following signs can be reliably used to diagnose urinary tract infection in the

elderly? A) Fever

 B) Foul-smelling urine C) White blood cell count

 D) None of the above

Page 65: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) None of the above

Page 66: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following is the most common causative

organism for pneumonia in the elderly?

 A) Haemophilus influenzae  B) Staphylococcus aureus 

 C) Streptococcus pneumoniae D) Mycoplasma pneumoniae

Page 67: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) Streptococcus pneumoniae

Page 68: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Initial therapy for vancomycin-resistant enterococci (VRE)

before cultures and sensitivities are known includes which of the

following?AmpicillinClindamycinGentamic

inA fluoroquinolone A) 1,3 B) 2,4

 C) 1,2,3 D) 4

Page 69: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• Ampicillin Gentamicin

•  A) 1,3

Page 70: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Long-term dialysis within 30 days is a risk factor for which of

the following cases? A) VRE

 B) Health care-associated pneumonia

 C) Clostridium difficile colitis D) Hospital-acquired pneumonia

Page 71: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Health care-associated pneumonia

Page 72: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

In C difficile colitis, the more severe the presentation, the more

likely diarrhea is present. A) True B) False

Page 73: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) False

Page 74: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Which of the following tests is the gold standard for the

diagnosis of C difficile colitis? A) Enzyme-linked immunoassay

 B) Computed tomography C) Cytotoxicity assay

 D) Stool culture

Page 75: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) Cytotoxicity assay

Page 76: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Dual antiplatelet therapy with aspirin and clopidogrel is

strongly recommended for stroke prevention in older patients with

atrial fibrillation (AF). A) True B) False

Page 77: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  B) False

Page 78: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Cholinesterase inhibitors increase the risk for all the following,except:

 A) Syncope B) Bradycardia

 C) Falls D) Stroke

Page 79: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) Stroke

Page 80: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

The Rate Control Efficacy in Permanent Atrial Fibrillation

(RACE II) study found that strict rate control produced slightly better outcomes than lenient control in patients with AF,

including those >80 yr of age. A) True B) False

Page 81: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) False

Page 82: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

In the treatment of mixed dyslipidemia, there is currently

 no target value for: A) Triglycerides (TGs) or low-density lipoprotein cholesterol

(LDL-C) B) TGs or high-density

lipoprotein cholesterol (HDL-C) C) LDL-C or HDL-C

Page 83: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) TGs or high-density lipoprotein cholesterol (HDL-C)

Page 84: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Compared with patients taking metformin or placebo, patients with impaired fasting

glucose and impaired glucose tolerance who achieved an initial loss of body weight of 7%

to 10% (via diet plus 150 min of moderate exercise 3 days/wk) had _______ of

progression to diabetes mellitus, according to a study by the Diabetes Prevention Program.

 A) The same rate B) A slightly faster rate C) A much slower rate

Page 85: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) A much slower rate

Page 86: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

 Choose the incorrect statement about hypertriglyceridemia and the risk for coronary heart

disease (CHD). A) Increases in TG levels do not correlate closely

with increased risk for CHD B) Increased TG levels correlate with increased risk for CHD, except in cases of very low LDL-C levels

 C) Increased TG levels tend to correlate with an increased risk for CHD only at extreme levels of

LDL-C D) Increased TG levels correlate with increased risk

for CHD at all levels of LDL-C

Page 87: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) Increased TG levels correlate with increased risk for CHD at all levels of LDL-C

Page 88: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

In patients with hypertriglyceridemia, lipid and lipoprotein metabolism is characterized

by all the following, except: A) Increased secretion of TG

 B) Increased conversion of very-low-density lipoprotein (VLDL) to LDL

 C) Impaired function of lipoprotein lipase D) Production of small dense LDL and HDL

particles

Page 89: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Increased conversion of very-low-density lipoprotein (VLDL) to LDL

Page 90: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Studies consistently show that _______ is superior to _______ for assessment of cardiovascular

(CV) risk and as the goal for therapy.

 A) Non-HDL-C; LDL-C B) LDL-C; non-HDL-C

Page 91: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  A) Non-HDL-C; LDL-C

Page 92: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

When used with a statin, which of the following agents increases the risk for associated myopathy?

 A) Niacin B) High-dose prescription fish

oil C) Fenofibrate D) Gemfibrozil

Page 93: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) Gemfibrozil

Page 94: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

It is estimated that approximately _______ million people in the United States currently take a

statin. A) 15.8 B) 29.7 C) 43.6 D) 68.3

Page 95: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• C) 43.6

Page 96: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Choose the incorrect statement about the clinical aspects of statin myopathy.

 A) Toxicity associated with statin use is rare

 B) Nonspecific muscle pain and weakness are more common than is frank

rhabdomyolysis C) Myalgias account for ≈25%

 D) Muscle symptoms and high serum creatine kinase always resolve quickly

with statin withdrawal

Page 97: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  D) Muscle symptoms and high serum creatine kinase always resolve quickly with statin withdrawal

Page 98: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Perifascicular atrophy is pathognomonic for which of the

following conditions: A) Toxic myopathy B) Dermatomyositis

 C) Becker muscular dystrophy D) Necrotizing myopathy

Page 99: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

• B) Dermatomyositis

Page 100: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Evidence indicates that statin-associated necrotizing myopathy

is _______ to immunosuppression.

 A) Responsive B) Not responsive

Page 101: Hypertension Kidney Stones Hypercholestrolemia. The prevalence of "true" treatment- resistant hypertension (HTN) is: A) Unknown B) Approximately 20% in

Answer

•  A) Responsive